BIOSISTEMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 985,075 | 1,188,823 | 1,300,335 | 1,587,241 | 876,063 | 995,620 | 1,227,752 | 1,321,284 |
| Profit before tax | 179,138 | 338,586 | 418,591 | 651,313 | 179,875 | 190,973 | 303,889 | 278,123 |
| Net profit | 140,426 | 282,280 | 353,359 | 548,873 | 149,288 | 158,710 | 255,226 | 230,087 |
| Equity | 533,146 | 631,427 | 765,139 | 1,314,012 | 1,263,000 | 755,044 | 833,770 | 712,557 |
| Liabilities | 92,315 | 174,728 | 220,163 | 220,906 | 100,378 | 145,745 | 166,680 | 147,623 |
| Non-current assets | 161,278 | 35,371 | 28,759 | 24,486 | 4,080 | 5,755 | 3,650 | 3,744 |
| Current assets | 338,324 | 722,126 | 901,313 | 1,465,300 | 1,355,374 | 887,915 | 938,820 | 789,172 |
| Total assets | 499,602 | 757,497 | 930,072 | 1,489,786 | 1,359,454 | 893,670 | 942,470 | 792,916 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 435,504 | 404,883 | 505,496 |
| Social insurance contributions | - | - | - | - | - | 138,194 | 162,474 | 179,671 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +14.1% | +20.7% | +9.4% | +22.1% | -44.8% | +13.6% | +23.3% | +7.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 28.1% | 37.3% | 38.0% | 36.8% | 11.0% | 17.8% | 27.1% | 29.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 26.3% | 44.7% | 46.2% | 41.8% | 11.8% | 21.0% | 30.6% | 32.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.3% | 23.7% | 27.2% | 34.6% | 17.0% | 15.9% | 20.8% | 17.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.2% | 28.5% | 32.2% | 41.0% | 20.5% | 19.2% | 24.8% | 21.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 88,879 | 119,881 | 139,322 | 156,122 | 42,909 | 47,790 | 53,967 | 57,240 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOSISTEMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.01 |
BIOSISTEMA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-08-31 | 2025-09-03 | 0.17 |
| 2025-08-28 | 2025-08-30 | 0.18 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOSISTEMA, UAB (code 300063053) is a Private Limited Liability Company engaged in environmental engineering and related consultancy activities. In the latest financial year, 2025, the company generated revenue of €1.32M and net profit of €230.1K, with a profit margin of 17.4%. Revenue increased by 7.6% year on year and by 32.7% over two years, showing a steady expansion from €995.6K in 2023 to €1.23M in 2024 and €1.32M in 2025. Profitability improved strongly in 2024, then moderated in 2025, but remained solid above the 2023 level. The balance sheet remained conservative, with total assets of €792.9K, equity of €712.6K and liabilities of €147.6K at year-end 2025. The equity ratio stood at 89.9%, while debt-to-equity was 0.21. Operational efficiency was strong, with asset turnover of 1.67x and revenue per employee of €57.4K. Return metrics were also high, with ROE at 32.3% and ROA at 29.0% in 2025.